Fluorothiazinon, a small-molecular inhibitor of T3SS, suppresses salmonella oral infection in mice

Inhibition of the type III secretion system by syringaldehyde protects mice from Salmonella enterica serovar Typhimurium

(2019) Qianghua Lv et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Non-traditional Antibacterial Therapeutic Options and Challenges

(2019) Ursula Theuretzbacher et al.   Cell Host & Microbe

Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice

(2018) Anna B. Sheremet et al.   Biomed Research International

Mechanisms of Salmonella pathogenesis in animal models

(2017) Alexander D. Palmer et al.   HUMAN AND ECOLOGICAL RISK ASSESSMENT

Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature

(2017) Ajitha Thanabalasuriar et al.   JOURNAL OF CLINICAL INVESTIGATION

Pharmacological Targeting of the Host–Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs

(2017) Jason Munguia et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones suppresses Salmonella infection in vivo

(2016) Ludmila N Nesterenko et al.   JOURNAL OF ANTIBIOTICS

High Throughput Combinatorial Formatting of PcrV Nanobodies for Efficient Potency Improvement

(2016) Evelyn De Tavernier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 ImpairsPseudomonas aeruginosaPathogenicity and Inflammasome Activation

(2016) Ahalieyah Anantharajah et al.   JOURNAL OF INFECTIOUS DISEASES

A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones inhibits intracellular growth and persistence of Chlamydia trachomatis

(2016) Naylia A. Zigangirova et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Alternatives to antibiotics—a pipeline portfolio review

(2016) Lloyd Czaplewski et al.   LANCET INFECTIOUS DISEASES

Targeting the Type Three Secretion System in Pseudomonas aeruginosa

(2016) Ahalieyah Anantharajah et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Salmonella enterica: living a double life in epithelial cells

(2015) Leigh A Knodler   CURRENT OPINION IN MICROBIOLOGY

Approaches targeting the type III secretion system to treat or prevent bacterial infections

(2015) Nuno Charro et al.   Expert Opinion on Drug Discovery

Small Molecule Inhibitor of Type Three Secretion Suppresses Acute and ChronicChlamydia trachomatisInfection in a Novel Urogenital Chlamydia Model

(2015) Ekaterina A. Koroleva et al.   Biomed Research International

The Bacterial Type III Secretion System as a Target for Developing New Antibiotics

(2014) Andrew C. McShan et al.   Chemical Biology & Drug Design

Targeting virulence: can we make evolution-proof drugs?

(2014) Richard C. Allen et al.   NATURE REVIEWS MICROBIOLOGY

Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence

(2014) John S. Gunn et al.   TRENDS IN MICROBIOLOGY

Identification of Salmonella Pathogenicity Island-2 Type III Secretion System Effectors Involved in Intramacrophage Replication of S. enterica Serovar Typhimurium: Implications for Rational Vaccine Design

(2013) R. Figueira et al.   mBio

Chemical Inhibitors of the Type Three Secretion System: Disarming Bacterial Pathogens

(2012) Miles C. Duncan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors

(2012) R. Figueira et al.   MICROBIOLOGY-SGM

Spread of Salmonella enterica in the body during systemic infection: unravelling host and pathogen determinants

(2011) Pietro Mastroeni et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

A comprehensive study of the contribution ofSalmonella entericaserovar Typhimurium SPI2 effectors to bacterial colonization, survival, and replication in typhoid fever, macrophage, and epithelial cell infection models

(2011) Michelle M.C. Buckner et al.   Virulence

A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium

(2010) Kyota Kimura et al.   JOURNAL OF ANTIBIOTICS